Format

Send to

Choose Destination
J Am Assoc Nurse Pract. 2014 Sep;26(9):465-70. doi: 10.1002/2327-6924.12156. Epub 2014 Jul 14.

Hypertrophic cardiomyopathy in adults: an overview.

Author information

1
Venice Regional Medical Center, Gulf Coast Cardiovascular Consultants, University of Cincinnati, Sarasota, Florida.

Abstract

PURPOSE:

To present an overview of clinical issues related to adults with hypertrophic cardiomyopathy (HCM), their presenting symptoms, diagnosis, physical examination findings, treatment, and follow-up care.

DATA SOURCES:

A comprehensive search of Medline (PubMed) and CINAHL was conducted using the key terms HCM, treatment, diagnosis, sudden cardiac death (SCD), and complications. This search yielded 21 articles used for this article. There were three reference books used for background, diagnosis, and treatment information as well.

CONCLUSIONS:

Although HCM is the most prevalent genetic disorder affecting the heart, it often goes undiagnosed until midlife after patients show symptoms of myocardial remodeling. Adults with cardiomyopathy suffer SCD or adverse events such as stroke and heart failure from HCM. Early diagnosis will prevent SCD, improve quality of life, and slow patient's progression to heart failure.

IMPLICATIONS FOR PRACTICE:

Early recognition of HCM in adults by their primary care providers will improve patients' quality of life and reduce incidence of SCD, heart failure, and stroke.

KEYWORDS:

Diastolic dysfunction; genetics; heart failure; primary care; sudden cardiac death

PMID:
25044876
DOI:
10.1002/2327-6924.12156
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center